2-substituted imidazoquinoxaline diones, a new class of GABA bra

Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544 80, 544115, 546278, 546306, 549480, 564 45, 564 50, C07D48704, C07D40104, C07D23372, A61K 31495

Patent

active

051304309

ABSTRACT:
The invention encompasses compounds of the formula: ##STR1## and the pharmaceutically acceptable non-toxic salts thereof wherein R.sub.1, R.sub.2, R.sub.3, and R.sub.4 represent organic or inorganic substituents; X represents hydrogen, halogen, hydroxy or amino and W represents phenyl, thienyl or pyridyl, each of which may be unsubstituted or mono or disubstituted with organic or inorganic substituents.
These compounds are highly selective agonists, antagonists or inverse agonists for GABA a brain receptors or prodrugs thereof and are useful in the diagnosis and treatment of anxiety, sleep, and seizure disorders, overdose with benzodiazepine drugs, and enhancement of memory.

REFERENCES:
patent: 4312870 (1982-01-01), Yokoyama
patent: 4440929 (1984-04-01), Lee
patent: 4713383 (1987-12-01), Francis

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-substituted imidazoquinoxaline diones, a new class of GABA bra does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-substituted imidazoquinoxaline diones, a new class of GABA bra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-substituted imidazoquinoxaline diones, a new class of GABA bra will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-335656

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.